The thermal dose axis: a hypothesis-generating perspective on the immune microenvironment of heating and non-heating surgical energies
Energy-based surgical platforms are physically diverse, yet their immunological consequences have received little systematic attention. This mini-review organizes fifteen platforms into a heating layer (electrosurgery, ultrasonic scalpels, advanced bipolar sealers, lasers, argon plasma coagulation, radiofrequency and microwave ablation, and high-intensity focused ultrasound [HIFU]) and a non-heating layer (water-jet dissection, ultrasonic aspiration, cryoablation, irreversible electroporation [IRE], and histotripsy), examining how thermal dose, as a heuristic construct, may shape the immune microenvironment. In the surgical studies reviewed, immune impact largely paralleled the thermal injury burden: necrotic tissue releases damage-associated molecular patterns that initiate TNF-α/IL-6 cascades through TLR4/RAGE–NF-κB, prolonging inflammatory healing and delaying macrophage phenotype switching; randomized studies found higher wound-drainage cytokines with electrosurgery than ultrasonic dissection, but systemic differences were transient and did not affect hard clinical endpoints. At the ablative extreme, HIFU deposited high energy in a small focal volume, left antigen-bearing debris in situ , activated antigen-presenting cells and tumor-draining nodes in patients, and synergized with checkpoint blockade preclinically, although standalone effects are weak and suppressor-cell recruitment occurs. In the non-heating layer, cryoablation, IRE, and histotripsy destroy tissue without heating (a boiling histotripsy variant involves localized heating) while preserving antigen; histotripsy additionally induced immunogenic cell death with functional support in animals, whereas water-jet dissection appears minimally immunogenic in available models. For several classes, no human cytokine-level or functional immune-endpoint studies exist, only animal or histological evidence. We propose the thermal-dose axis as a hypothesis-generating perspective organizing the evidence gaps between mechanistic promise and clinical benefit; it requires prospective validation.
Authors
- Ruifeng Shi (ORCID: https://orcid.org/0009-0001-8780-7477)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1965148
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00